Texas Permanent School Fund Trims Stake in Amedisys Inc (AMED)

Texas Permanent School Fund lowered its holdings in shares of Amedisys Inc (NASDAQ:AMED) by 7.2% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 19,270 shares of the health services provider’s stock after selling 1,495 shares during the quarter. Texas Permanent School Fund owned approximately 0.06% of Amedisys worth $1,016,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in the company. UBS Asset Management Americas Inc. increased its holdings in Amedisys by 23.9% in the 2nd quarter. UBS Asset Management Americas Inc. now owns 14,572 shares of the health services provider’s stock worth $915,000 after acquiring an additional 2,812 shares in the last quarter. Vanguard Group Inc. increased its holdings in Amedisys by 0.7% in the 2nd quarter. Vanguard Group Inc. now owns 2,386,046 shares of the health services provider’s stock worth $149,867,000 after acquiring an additional 16,368 shares in the last quarter. California Public Employees Retirement System increased its holdings in Amedisys by 1.1% in the 2nd quarter. California Public Employees Retirement System now owns 62,300 shares of the health services provider’s stock worth $3,913,000 after acquiring an additional 700 shares in the last quarter. Parametric Portfolio Associates LLC increased its holdings in Amedisys by 38.3% in the 2nd quarter. Parametric Portfolio Associates LLC now owns 101,560 shares of the health services provider’s stock worth $6,379,000 after acquiring an additional 28,133 shares in the last quarter. Finally, Royal Bank of Canada increased its holdings in Amedisys by 1,320.7% in the 2nd quarter. Royal Bank of Canada now owns 6,237 shares of the health services provider’s stock worth $392,000 after acquiring an additional 5,798 shares in the last quarter. 93.73% of the stock is owned by hedge funds and other institutional investors.

Shares of Amedisys Inc (NASDAQ AMED) opened at $56.05 on Thursday. The company has a current ratio of 1.33, a quick ratio of 1.33 and a debt-to-equity ratio of 0.16. Amedisys Inc has a fifty-two week low of $45.60 and a fifty-two week high of $65.91. The stock has a market cap of $1,878.40, a P/E ratio of 44.84, a price-to-earnings-growth ratio of 1.16 and a beta of 0.73.

AMED has been the subject of several analyst reports. SunTrust Banks reissued a “buy” rating and issued a $70.00 target price on shares of Amedisys in a report on Friday, November 10th. Craig Hallum reissued a “buy” rating and issued a $68.00 target price (up from $55.00) on shares of Amedisys in a report on Thursday, November 9th. Mizuho reaffirmed a “buy” rating and set a $65.00 price objective (up from $55.00) on shares of Amedisys in a report on Wednesday, November 8th. Benchmark raised shares of Amedisys from a “hold” rating to a “buy” rating and set a $56.00 price objective for the company in a report on Thursday, November 2nd. Finally, Zacks Investment Research raised shares of Amedisys from a “hold” rating to a “buy” rating and set a $61.00 price objective for the company in a report on Friday, January 12th. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and seven have issued a buy rating to the company. Amedisys currently has an average rating of “Hold” and an average price target of $60.64.

TRADEMARK VIOLATION NOTICE: This piece of content was published by Week Herald and is owned by of Week Herald. If you are viewing this piece of content on another site, it was stolen and republished in violation of U.S. and international copyright legislation. The legal version of this piece of content can be viewed at https://weekherald.com/2018/02/15/texas-permanent-school-fund-trims-stake-in-amedisys-inc-amed.html.

Amedisys Company Profile

Amedisys, Inc is a healthcare services company. The Company’s segments are Home Health, Hospice, Personal Care and Other. The Company is a provider of home health, hospice and personal care services. As of December 31, 2016, the Company owned and operated 327 Medicare-certified home healthcare centers, 79 Medicare-certified hospice care centers and 14 personal-care care centers in 34 states within the United States and the District of Columbia.

Want to see what other hedge funds are holding AMED? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amedisys Inc (NASDAQ:AMED).

Institutional Ownership by Quarter for Amedisys (NASDAQ:AMED)

Receive News & Ratings for Amedisys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amedisys and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply